secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001682852-23-000044
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna CCO cancels 10b5-1 trading plan; no trades executed
-----------------------------------------------------------

- Arpa Garay, Chief Commercial Officer, adopted a 10b5-1 plan on August 24, 2023.
- Plan cancelled on November 6, 2023, following disclosure of Q3 2023 results.
- Sales under the plan were to begin no earlier than November 27; no shares sold or options exercised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285223000044/0001682852-23-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285223000044/mrna-20231106.htm
  HTML page:      https://secwatch.observer/filing/0001682852-23-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer